CapsoVision, Inc. (CV) vs Embecta Corp. (EMBC)
A side-by-side comparison of CapsoVision, Inc. and Embecta Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CV
CapsoVision, Inc.
$6.50HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
EMBC
Embecta Corp.
$5.95HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CV vs EMBC
growth of $100 · dividends reinvested · last 1yCV +88.3% (+88.3%/yr)EMBC -40.1% (-40.1%/yr)CV compounded faster over this window
CV EMBC
CV vs EMBC: by the numbers
- •EMBC is the larger company ($353M vs $325M market cap).
- •EMBC is profitable (8.59% net margin) while CV runs a net loss (-214.74%).
- •EMBC pays a dividend (5.44% yield), while CV has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CV | EMBC |
|---|---|---|
| P/E ratio | N/A | 4.02 |
| Forward P/E | N/A | 3.38 |
| P/S ratio | 23.38 | 0.35 |
| P/B ratio | 24.67 | N/A |
| EV / EBITDA | N/A | 5.38 |
| FCF yield | N/A | 46.63% |
Profitability
| Metric | CV | EMBC |
|---|---|---|
| Gross margin | 50.88% | 59.89% |
| Operating margin | -188.25% | 24.85% |
| Net margin | -214.74% | 8.59% |
| ROE | -226.56% | N/A |
| ROIC | -164.32% | 17.99% |
Dividends
| Metric | CV | EMBC |
|---|---|---|
| Dividend yield | N/A | 5.44% |
| Payout ratio | N/A | 21.62% |
Growth (annualized)
| Metric | CV | EMBC |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -0.09% |
| EPS CAGR (5Y) | N/A | -26.22% |
| FCF CAGR (5Y) | N/A | -16.77% |
Frequently asked
- Does CV or EMBC pay a bigger dividend?
- EMBC pays a dividend (5.44% yield), while CV has no payments in the available dividend history.
- Is CV or EMBC more profitable?
- EMBC runs the higher net margin — CV at -214.74% versus EMBC at 8.59%.
Go deeper
Dig into the metrics
Embecta P/E ratioEmbecta dividend yieldCapsoVision ROEEmbecta ROECapsoVision operating marginEmbecta operating marginCapsoVision revenue growthEmbecta revenue growthCapsoVision free cash flowEmbecta free cash flow
CapsoVision & Embecta appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.